๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of myasthenia gravis with mycophenolate mofetil: A case report

โœ Scribed by Matthew N. Meriggioli; Julie Rowin

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
87 KB
Volume
23
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

โœฆ Synopsis

We report a patient with myasthenia gravis (MG) who had marked clinical benefit in response to treatment with mycophenolate mofetil as documented by serial quantitative measures of strength and muscle fatigue. Our patient had experienced either adverse side effects or a suboptimal response to the usual immunosuppressive agents used in MG. Mycophenolate mofetil was used in combination with cyclosporine and prednisone and allowed for significant reductions in dosage of these immunosuppressants. We conclude that mycophenolate mofetil deserves further study as a therapeutic agent in MG. In particular, its role as a steroid-sparing agent and as a drug to be used in combination immunotherapy in more severe or refractory cases of MG should be investigated.

๐Ÿ“œ SIMILAR VOLUMES

Treatment of agnogenic myeloid metaplasi
Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases
โœ Lรฉvy, V.; Bourgarit, A.; Delmer, A.; Legrand, O.; Baudard, M.; Rio, B.; Zittoun, ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 235 KB ๐Ÿ‘ 1 views

Peripheral cytopenias are common in patients with agnogenic myeloid metaplasia (AMM). They are an important cause of morbidity and mortality, and their treatment is difficult. We report on 4 patients with AMM and severe cytopenia treated with danazol (400-600 mg/ day). Three of them became independe